We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPWR
326
DELISTED
SunPower Corporation Common Stock
SPWR
| $16.8M | 0.08% |
1,710,944
+1,517,131
| +783% | +$17.7M |
|
327
Hartford Financial Services
HIG
$38.1B
| $16.7M | 0.08% |
232,513
+162,995
| +234% | +$11.4M |
|
328
Estee Lauder
EL
$31.8B
| $16.7M | 0.08% |
85,127
+73,977
| +663% | +$15.7M |
|
329
Toll Brothers
TOL
$14.3B
| $16.7M | 0.08% |
210,965
-86,294
| -29% | -$5.79M |
|
330
United Rentals
URI
$71.2B
| $16.7M | 0.08% |
37,391
-206,664
| -85% | -$76.6M |
|
331
Patterson-UTI
PTEN
$4.22B
| $16.6M | 0.08% |
1,389,313
+805,176
| +138% | +$9.09M |
|
332
Monster Beverage
MNST
$89.2B
| $16.6M | 0.08% |
576,848
+58,610
| +11% | +$1.67M |
|
333
Home Depot
HD
$353B
| $16.6M | 0.08% |
53,324
-11,151
| -17% | -$3.29M |
|
334
Abercrombie & Fitch
ANF
$5.24B
| $16.5M | 0.08% |
438,609
-753
| -0.2% | -$21.5K |
|
335
EXL Service
EXLS
$5.29B
| $16.5M | 0.08% |
546,875
+302,045
| +123% | +$9.53M |
|
336
West Pharmaceutical
WST
$24.7B
| $16.5M | 0.08% |
+43,198
| New | +$15.4M |
|
337
Manulife Financial
MFC
$72.7B
| $16.5M | 0.08% |
871,606
-85,161
| -9% | -$1.63M |
|
338
Nutanix
NTNX
$17.4B
| $16.4M | 0.08% |
586,250
-139,318
| -19% | -$3.7M |
|
339
Equity Residential
EQR
$24.4B
| $16.3M | 0.08% |
247,826
-420,906
| -63% | -$26.3M |
|
340
Northern Trust
NTRS
$34.4B
| $16.3M | 0.08% |
219,734
+209,656
| +2,080% | +$16.1M |
|
341
TG Therapeutics
TGTX
$7.64B
| $16.2M | 0.08% |
653,580
-559,959
| -46% | -$14.5M |
|
342
Azenta
AZTA
$1.46B
| $16.2M | 0.08% |
346,966
+74,444
| +27% | +$3.26M |
|
343
Dell
DELL
$285B
| $16.2M | 0.08% |
299,080
+266,929
| +830% | +$12.3M |
|
344
Choice Hotels
CHH
$4.62B
| $16.2M | 0.08% |
137,673
+48,480
| +54% | +$5.82M |
|
345
British American Tobacco
BTI
$122B
| $16.2M | 0.08% |
487,059
-646,154
| -57% | -$22.1M |
|
346
Morgan Stanley
MS
$338B
| $16M | 0.08% |
187,691
-151,750
| -45% | -$13M |
|
347
Extreme Networks
EXTR
$3.14B
| $16M | 0.08% |
614,871
+462,753
| +304% | +$9.13M |
|
348
Chegg
CHGG
$92.8M
| $15.9M | 0.08% |
1,795,740
+608,242
| +51% | +$7.38M |
|
|
AMED
349
DELISTED
Amedisys
AMED
| $15.9M | 0.08% |
173,750
+54,821
| +46% | +$4.5M |
|
350
Xylem
XYL
$28.8B
| $15.8M | 0.07% |
140,506
-86,788
| -38% | -$9.18M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.